FIELD: medicine. SUBSTANCE: method involves administering a biologically active additive two days before chemotherapy beginning at a dose of 10-15 ml twice a day. Leukocyte number in blood and transaminases level are determined before and after administering the chemotherapy course. Leukocyte number being below 3,3×109/l 3,0×109/l and/or transaminases level being 1.5-2 times as high as a norm, the preparation dose is doubled. The preparation is diluted with 0.9% physiological salt solution. EFFECT: enhanced effectiveness of treatment; reduced risk of complications.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATMENT OF LOCALLY SPREAD BREAST CANCER IN PREOPERATIVE PERIOD (VARIANTS) | 2002 |
|
RU2207862C2 |
| METHOD OF TREATING PATIENTS SUFFERING LOCALLY ADVANCED CERVICAL CANCER | 2014 |
|
RU2547569C1 |
| BREAST CANCER CHEMOTHERAPY PROCEDURE | 2008 |
|
RU2372917C1 |
| FOODSTUFF KIT FOR WEEKLY DIET FOR ONCOLOGY PATIENTS AND LONG-LIVERS | 2005 |
|
RU2286679C1 |
| METHOD OF TREATING MAMMAL GLAND CANCER | 2000 |
|
RU2169014C1 |
| PREPARATION ELICITING IMMUNOMODULATING ACTIVITY | 2002 |
|
RU2200023C1 |
| METHOD OF NEOADJUVANT CHEMOTHERAPY OF MAMMARY GLAND CANCER | 2007 |
|
RU2338545C1 |
| METHOD OF TREATING NON-HODGEKIN LYMPHOMAS | 2012 |
|
RU2493858C1 |
| METHOD OF COMBINATION TREATMENT OF PATIENTS WITH LOCALLY ADVANCED STOMACH CANCER | 2011 |
|
RU2461375C1 |
| METHOD FOR TREATING MAMMARY GLAND CARCINOMA IN EXPERIMENT | 2005 |
|
RU2291497C1 |
